Responsibility statement for first half year of 2024
Please find attached the first half 2024 financial report including the Responsibility Statement.***** For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 [email protected] information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Vistin Pharma ASA Q2 report 2024
Comunicato Precedente
Comunicato Successivo
Oslo,
(informazione.it - comunicati stampa - salute e benessere)
Please find attached the first half 2024 financial report including the Responsibility Statement.
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
Per maggiori informazioni
Sito Web
https://www.vistin.com/
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
